Sectors
MAZE
Maze Therapeutics, Inc.
28.65
14 x 28.59
10 x 28.66
bid
ask
+
0.12
0.42%
undefined @ 04:00 PM
28.09 -0.56 (1.95%)
| Ytd | -30.85% | |
| 1y | 115.09% |
27.45
day range
28.99
13.14
52 week range
51.83
| Open | 28.95 | Prev Close | 28.53 | Low | 27.45 | High | 28.99 | Mkt Cap | 1.59B |
| Vol | 475.20K | Avg Vol | 586.19K | EPS | -2.53 | P/E | -11.32 | Forward P/E | 8.53 |
| Beta | 2.21 | Short Ratio | 7.14 | Inst. Own | 96.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 27.28 | 200-d Avg | 34.56 | 1yr Est | 62.55 |
| Income Statement | |||
| Total Revenue | 20.00M | ||
| Revenues (USD) | 20.00M | ||
| Gross Profit | 20.00M | ||
| Operating Expenses | 46.55M | ||
| Research and Development Expense | 34.15M | ||
| Selling, General and Administrative Expense | 12.41M | ||
| Operating Income | -26.55M | ||
| Interest Expense | 866.00K | ||
| Net Income | -24.21M | ||
| Net Income Common Stock | -24.21M | ||
| Net Income Common Stock (USD) | -24.21M | ||
| Consolidated Income | -24.21M | ||
| Earnings per Basic Share | -0.45 | ||
| Earnings per Basic Share (USD) | -0.45 | ||
| Earnings per Diluted Share | -0.45 | ||
| Earning Before Interest & Taxes (EBIT) | -23.34M | ||
| Earning Before Interest & Taxes (USD) | -23.34M | ||
| Weighted Average Shares | 53.90M | ||
| Weighted Average Shares Diluted | 53.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 199.85M | ||
| Cash and Equivalents (USD) | 199.85M | ||
| Investments | 164.17M | ||
| Investments Current | 153.62M | ||
| Investments Non-Current | 10.56M | ||
| Trade and Non-Trade Receivables | 20.00M | ||
| Current Assets | 379.78M | ||
| Property, Plant & Equipment Net | 23.97M | ||
| Total Assets | 419.71M | ||
| Debt Current | 4.84M | ||
| Total Debt | 61.22M | ||
| Current Liabilities | 21.24M | ||
| Debt Non-Current | 56.39M | ||
| Total Liabilities | 78.01M | ||
| Accumulated Retained Earnings (Deficit) | -513.75M | ||
| Accumulated Other Comprehensive Income | -135.00K | ||
| Shareholders Equity | 341.70M | ||
| Shareholders Equity (USD) | 341.70M | ||
| Assets Non-Current | 39.93M | ||
| Total Debt (USD) | 61.22M | ||
| Liabilities Non-Current | 56.77M | ||
| Trade and Non-Trade Payables | 4.01M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.27M | ||
| Net Cash Flow from Financing | 42.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.52M | ||
| Capital Expenditure | -93.00K | ||
| Issuance (Purchase) of Equity Shares | 4.08M | ||
| Issuance (Repayment) of Debt Securities | 38.52M | ||
| Net Cash Flow from Investing | 6.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.37M | ||
| Net Cash Flow from Operations | -39.11M | ||
| Share Based Compensation | 7.11M | ||